Developer synthesizes PAC-3310, a ChatGPT-designed schizophrenia drug candidate, in his garage
CatAstro_Piyush · x · 2026-09-09
Developer Douglas Yao showed off a vial of PAC-3310, a novel compound designed with ChatGPT and synthesized in a garage chemistry lab he built.
- PAC-3310 is a selective M4 muscarinic receptor agonist targeting schizophrenia
- Modeled after the recent breakthrough drug Cobenfry (KarXT), but claimed to be improved
- A rare hands-on AI4Science case of an individual using AI for drug design; his follow-up posts are worth watching to verify the claims
Related event: Biochemist synthesizes ChatGPT-designed schizophrenia drug in garage lab(4 posts)→
More from Research
- Diamandis: AI Cancer Navigator and $100 Genome Sequencing Close the Care Gap — PeterDiamandis · 2026-10-27
- EMNLP Oral: training-free Nexus Sampling cuts KV-cache memory 10x; OpenResearcher tops BrowseComp-Plus at 54.8% — yuz9yuz · 2026-10-27
- ICML 2026 position paper: LLM 'thinking traces' are a harmful anthropomorphism — rao2z · 2026-10-27
- Forking gap follows a power law in context frequency; masking rare n-grams shrinks it — ZimingLiu11 · 2026-10-27
- How forking happens: n-gram tables split logits into non-interacting subspaces — ZimingLiu11 · 2026-10-27
- The best LoRA explainer video yet: rank constraints meet intrinsic dimension — sophiamyang · 2026-10-27